Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor κb activity and cytokine expression in rats with diastolic dysfunction

Hypertension

Volumn 55, Issue 5, 2010, Pages 1179-1185

  Seymour, E Mitchell ^a,b   Bennink, Maurice R ^b   Watts, Stephanie W ^b   Bolling, Steven F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Anthocyanin; Antioxidant; Hypertension; Hypertrophy; Inflammation

Indexed keywords

ANTHOCYANIN; ANTIOXIDANT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DAHL SALT SENSITIVE RAT; DIET SUPPLEMENTATION; GRAPE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARDIOTONIC AGENTS; CYTOKINES; DIASTOLE; HEART FAILURE, DIASTOLIC; NF-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA; PPAR GAMMA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VITIS;

EID: 77951499920     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.149393     Document Type: Article

References (40)

1. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124.
2. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.
3. Doyle L, Cashman KD. The effect of nutrient profiles of the Dietary Approaches to Stop Hypertension (DASH) diets on blood pressure and bone metabolism and composition in normotensive and hypertensive rats. Br J Nutr. 2003;89:713-724. (Pubitemid 36592098)
4. Seymour EM, Singer AA, Bennink MR, Parikh RV, Kirakosyan A, Kaufman PB, Bolling SF. Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension. J Gerontol A Biol Sci Med Sci. 2008; 63:1034-1042.
5. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B. Peroxisome proliferator-activated receptor a negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999;274:32048-32054. (Pubitemid 129503797)
6. Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IKBCK expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-a activators. J Biol Chem. 2000;275:36703-36707. (Pubitemid 32002075)
7. Goikoetxea MJ, Beaumont J, Gonzalez A, Lopez B, Querejeta R, Larman M, Diez J. Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. Car-diovasc Res. 2006;69:899-907. (Pubitemid 43227988)
8. Schupp M, Kintscher U, Fielitz J, Thomas J, Pregla R, Hetzer R, Unger T, Regitz-Zagrosek V. Cardiac PPARa expression in patients with dilated cardiomyopathy. Eur J Heart Fail. 2006;8:290-294. (Pubitemid 43674490)
9. Ichihara S, Noda A, Nagata K, Obata K, Xu J, Ichihara G, Oikawa S, Kawanishi S, Yamada Y, Yokota M. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Cardiovasc Res. 2006;69:726-735. (Pubitemid 43139735)
10. Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Nishizawa T, Noda A, Izawa H, Nagata K, Murohara T, Yokota M. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure. J Cardiovasc Pharmacol. 2006;47:770-779. (Pubitemid 44305251)
11. Stafylas PC, Sarafidis PA, Lasaridis AN. The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality. Int J Cardiol. 2009;131:298-304.
12. Campbell IW. The clinical significance of PPAR yagonism. Curr Mol Med. 2005;5:349-363.
13. Gupta S, Sen S. Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts. J Mol Med. 2005;83: 993-1004. (Pubitemid 41745758)
14. Purcell NH, Molkentin JD. Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? Circulation. 2003;108: 638-640.
15. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol. 2008;375:637-649.
16. Frantz S, Hu K, Bayer B, Gerondakis S, Strotmann J, Adamek A, Ertl G, Bauersachs J. Absence of NF-{kappa}B subunit p50 improves heart failure after myocardial infarction. FASEB J. 2006;20:1918-1920. (Pubitemid 44933779)
17. Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-a activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. J Am Coll Cardiol. 2004;43:1481-1488. (Pubitemid 38496358)
18. Smeets PJ, Teunissen BE, Planavila A, de Vogel-van den Bosch H, Willemsen PH, van der Vusse GJ, van Bilsen M. Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARa and PPARA. J Biol Chem. 2008;283:29109-29118.
19. Kao ES, Tseng TH, Lee HJ, Chan KC, Wang CJ. Anthocyanin extracted from Hibiscus attenuate oxidized LDL-mediated foam cell formation involving regulation of CD36 gene. Chem Biol Interact. 2009;179: 212-218.
20. Wang Q, Xia M, Liu C, Guo H, Ye Q, Hu Y, Zhang Y, Hou M, Zhu H, Ma J, Ling W. Cyanidin-3-O-/3-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor Deactivation in THP-1 macrophages. Life Sci. 2008;83:176-184.
21. Xia M, Hou M, Zhu H, Ma J, Tang Z, Wang Q, Li Y, Chi D, Yu X, Zhao T, Han P, Xia X, Ling W. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {y}-liver X receptor {a }-ABCA1 pathway. J Biol Chem. 2005;280:36792-36801. (Pubitemid 41587759)
22. Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, Liu J, Ando K, Fujita T. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension. 2006;48:225-231. (Pubitemid 44309816)
23. Seymour EM, Parikh RV, Singer AA, Bolling SF. Moderate calorie restriction improves cardiac remodeling and diastolic dysfunction in the Dahl-SS rat. J Mol Cell Cardiol. 2006;41:661-668.
24. Li B, Dedman JR, Kaetzel MA. Nuclear Ca2+/calmodulin-dependent protein kinase II in the murine heart. Biochim Biophys Acta. 2006;1763: 1275-1281. (Pubitemid 44779870)
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-AAC(T)) Method. Methods. 2001; 25:402-408. (Pubitemid 34164012)
26. Tarmonova L, Shutov AM, Chernysheva EV. Factors influencing left ventricular diastolic function in elderly patients with chronic heart failure [in Russian]. Klin Med (Mosk). 2007;85:26-29.
27. Ichihara S, Obata K, Yamada Y, Nagata K, Noda A, Ichihara G, Yamada A, Kato T, Izawa H, Murohara T, Yokota M. Attenuation of cardiac dysfunction by a PPAR-a agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol. 2006;41: 318-329. (Pubitemid 44080222)
28. Diep QN, Amiri F, Benkirane K, Paradis P, Schiffrin EL. Long-term effects of the PPAR yactivator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. Can J Physiol Pharmacol. 2004;82:976-985. (Pubitemid 40223210)
29. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711. (Pubitemid 26052456)
30. Aharinejad S, Krenn K, Paulus P, Schafer R, Zuckermann A, Grimm M, Abraham D. Differential role of TGF-/31/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant. 2005;5:2185-2192. (Pubitemid 41648465)
31. Kubota T, Miyagishima M, Frye CS, Alber SM, Bounoutas GS, Kadokami T, Watkins SC, McTiernan CF, Feldman AM. Overexpression of tumor necrosis factor-activates both anti-and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol. 2001;33:1331-1344. (Pubitemid 32613425)
32. Bolger AP, Anker SD. Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs. 2000;60:1245-1257.
33. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 1990;85:507-514.
34. Battling obesity and hypertension: does the DASH diet really reduce blood pressure? AWHONN Lifelines. 2002;6:21-23.
35. Ogata T, Miyauchi T, Sakai S, Irukayama-Tomobe Y, Goto K, Yamaguchi I. Stimulation of peroxisome-proliferator-activated receptor a(PPARa) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci (Lond). 2002;103(suppl 48): 284S-288S. (Pubitemid 35007171)
36. Linz W, Wohlfart P, Baader M, Breitschopf K, Falk E, Schafer HL, Gerl M, Kramer W, Rutten H. The peroxisome proliferator-activated receptor-a (PPAR-a) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats. Acta Pharmacol Sin. 2009; 30:935-946.
37. Cantos E, Espin JC, Tomas-Barberan FA. Varietal differences among the polyphenol profiles of seven table grape cultivars studied by LC-DAD-MS-MS. J Agric Food Chem. 2002;50:5691-5696.
38. Seymour EM, Singer AA, Kirakosyan A, Urcuyo-Llanes DE, Kaufman PB, Bolling SF. Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator-activated receptors in rats with intake of tart cherry. J Med Food. 2008;11:252-259. (Pubitemid 351948185)
39. Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-a, PPAR-y, and LPL mRNA expressions. Life Sci. 2005;77:3344-3354.
40. Levitan EB, Wolk A, Mittleman MA. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med. 2009;169:851-857.